CONQUERing Myeloma™Multiple Myeloma

Making Sure Your Treatment Team Stays Connected

Patient Advocates Jack Aiello and Nancy Kaufmann stress the importance of communication and share tips to stay in sync with the treatment team.
August 2018 Vol 4 No 4
Jack Aiello
Patient Advocate
Multiple Myeloma Survivor
San Jose, CA
Nancy Kaufmann
Patient Advocate
Columbus, OH

This special feature and the Global Patient Leadership Council Multiple Myeloma Roundtable were sponsored and moderated by Takeda Oncology. Jack Aiello and Nancy Kaufmann are paid consultants of Takeda.

Takeda Oncology is the oncology business unit brand of Takeda Pharmaceutical Company Limited. All trademarks are the property of their respective owners. ©2018 Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited.

One of the many things that you probably did after receiving a diagnosis of multiple myeloma was to select a doctor and care team. They helped you to learn about multiple myeloma and how to navigate the complexities of treatment decision-making.

As you have continued with your multiple myeloma journey, your relationships with members of the treatment team have grown. New team members may have come into the mix as your medical needs have changed. For example, if you underwent a stem-cell transplant procedure, a transplant doctor and specialized team of nurses and care coordinators cared for you.

Surveys and studies of patients with cancer show that clear, timely communication among all team members—including your treatment team, other specialists, and caregivers—is critical. This communication is especially important during certain milestones in your multiple myeloma journey, such as:

  • When you are first diagnosed
  • Once treatment decisions need to be made, for example, deciding whether stem-cell transplant is the right decision for you
  • Upon relapse, if you’re experiencing side effects, or any time things change, and new treatment decisions need to be made
  • After a period of treatment, when discussing the results
  • When you need a referral to another specialist, such as a cardiologist or a pain specialist
  • When the goals of your care change and you need to make decisions about things such as advance directives, living will, and end-of-life care.

As the treatment team has evolved and new members have come in, are you sure that they are actively communicating with each other about your care? If you have had a stem-cell transplant, is your transplant doctor communicating with your oncologist after your follow-up visits to the transplant hospital? What about your visit to a multiple myeloma expert at a large cancer center? Is he or she communicating with your local oncologist after seeing you? Is your primary care physician aware of the details of your multiple myeloma journey?

Communicating with your Treatment Team is Critical

A survey conducted by Takeda Oncology and The Lynx Group in April and May 2017 showed that more than 400 people with multiple myeloma identify their hematologist/oncologist (78%) and primary care physician (61%) as key members of their treatment team (see Figure 1).

As a follow-up to this survey, a group of patients, caregivers, advocacy group leaders, nurse practitioners, and nurse navigators were brought together at the Multiple Myeloma Patient Advocacy Roundtable. They discussed the survey results and provided personal insights on key topics, including treatment team communications.

The roundtable participants agreed that survey responders showed they were interacting with key team members, but they were particularly surprised to see that only 61% of the patients listed primary care physician as part of their treatment team. The participating healthcare professionals discussed the challenges that they face when patients with cancer want their oncology office to serve a double role as their primary care office.

One participant stated, “The fact that only 61% said their primary care physician was part of their team is concerning. In my mind, 100% of people should say that a primary care physician is involved in their cancer care.”

Another participant said, “This is a problem for us, too. Many of our patients will say, ‘But, you are my primary care doctor.’ I explain to them that we are not their primary care physician, but I realize the problem; it means yet another doctor’s appointment. When you start adding up all the doctor visits, it is a lot for people and their caregivers to manage.”

Another question in the survey asked patients with multiple myeloma about other medical conditions, and whether they are regularly seeing a physician to manage them. Although approximately 30% of the survey responders reported having high blood pressure, and approximately 34% reported having high cholesterol, most patients with these conditions do not regularly see a physician to manage them (see Figure 2).

Several roundtable participants were also troubled about patients with cancer who do not go to dentists and optometrists, or do not get regular annual physical exams by their primary care physician.

The healthcare professionals participating in the roundtable emphasized the importance of patients with multiple myeloma continuing to see other physicians for medical conditions that are not related to their multiple myeloma.

One participant pointed out, “Your oncologist and treatment team are not thinking about testing your PSA [prostate-specific antigen] if you’re a man; we do not check it. If you’re a woman, we do not ask if you’ve had your mammogram. We are not experts in managing high blood pressure, high cholesterol, or diabetes, but patients with multiple myeloma still have these problems. These conditions don’t go away just because you’ve been diagnosed with cancer.”

How the Team Members Communicate

In addition to talking with each other in person and via telephone, members of your treatment team have sophisticated tools that they use to keep each other up to date. One of the most important tools is their electronic medical record, or EMR, systems. You can think of your EMR as a computerized version of your medical chart. The EMR contains all the medical and clinical information that has been gathered in your doctor’s office.

In addition to being more secure and durable, an EMR allows your treatment team to:

  • Monitor changes in your health status over time
  • Identify if you are due for a specific visit, such as lab work, scans, or other studies
  • Improve overall quality of care.

Your provider’s office can give you full access to your medical record. By accessing your EMR, you can see your medical details, including lab results, and learn follow-up information after an office visit or a hospital stay, including self-care instructions, reminders about follow-up care, and links to Internet resources. For more information about EMRs visit

Communication Tips for Your Treatment Team

The roundtable participants recommended several steps to help your treatment team communicate well.

1. Be Your Own Advocate

  • Share important medical information with your treatment team at each visit. Bring a diary or notebook with your updates, questions, and concerns.
  • Learn the names of your medications and their dosages (the number of times to take each day, and the amount), and keep track of your lab results (including the date of the test). There are numerous mobile apps that can help you manage your medications and provide reminders.
  • Do not allow yourself to be rushed if your doctor or nurse seems busy.
  • Ask questions to make sure team members are communicating with each other:
    • “Doctor, did you see my latest test results? The nurse said my blood counts were low.”
    • “Did the infusion nurse tell you that I had a reaction to my medication?”
  • Tell each doctor about other doctors who care for you, and all the medications you are taking.
  • If you have a cardiologist for your heart disease or an endocrinologist for your diabetes care, tell your oncology team. Tell your cardiologist that you have cancer and are being treated by an oncologist.
  • Make sure your doctors are communicating with each other about your care.

2. Enlist Your Caregiver(s) to Use Available Communications Tools

  • Your caregiver can update your nurse or patient navigator, pharmacist, financial advocate, and social worker as treatments change and as new decisions are made.
  • You and your caregiver can e-mail your treatment team members through electronic patient portals. Although there are times when an urgent phone call is necessary, many nonurgent questions and needs can be handled electronically.
  • Fully informed team members are a key element of well-coordinated care for patients with multiple myeloma. Your doctors, nurses, and pharmacists must be updated on your medical history and status as they make treatment recommendations and monitor your health. As your treatments and care plan change, it is critical for everyone to stay informed.

More to Come

This is the fourth of 5 articles that highlight recommendations from participants in the Multiple Myeloma Patient Advocacy Roundtable. Look for the last article, which will provide important tips and resources related to managing the cost of your multiple myeloma care.

View all CONQUERing Myeloma articles
Recommended For You
Multiple MyelomaPatient Stories
Living with the Ongoing Fear of a Multiple Myeloma Relapse
By Alyssa Dickey
Alyssa Dickey searched for 2 years for the source of her recurrent illnesses before she was diagnosed with multiple myeloma. Now, she tries to find balance in her life and live in the present, knowing that the cancer will likely return.
Multiple Myeloma
What Your Doctor Should Know: Which Treatment Is Best for a Patient with Relapsed or Refractory Multiple Myeloma?
By Meg Barbor, MPH
Many medications for multiple myeloma have been approved in recent years. That is great for patients, but it becomes even more important that doctors choose the best treatment for each patient.
Multiple Myeloma
Drugs for Multiple Myeloma
Here are the drugs and financial support services available to patients receiving treatment for Multiple Myeloma.
Multiple Myeloma
New Study Shows Racial Disparities Still Common in the Treatment of Patients with Multiple Myeloma
By Dana Taylor
Among Americans diagnosed with multiple myeloma, black and Hispanic patients receive their first treatment about 3 months later than white patients. Delays in treatment means unnecessary complications. Closing this racial gap is therefore paramount.
Last modified: October 10, 2018

Subscribe to CONQUER: the patient voice magazine

Receive timely cancer news & updates, patient stories, and more.